Skip to main content

Peer Review reports

From: Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Original Submission
1 May 2014 Submitted Original manuscript
1 May 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 2
1 May 2014 Submitted Manuscript version 2
1 May 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 3
1 May 2014 Submitted Manuscript version 3
29 May 2014 Reviewed Reviewer Report - Brian Gabrielli
29 Jun 2014 Reviewed Reviewer Report - Ratna Vadlamudi
7 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 4
7 Jul 2014 Submitted Manuscript version 4
16 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 5
16 Jul 2014 Submitted Manuscript version 5
21 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 6
21 Jul 2014 Submitted Manuscript version 6
Publishing
28 Jul 2014 Editorially accepted
7 Aug 2014 Article published 10.1186/1471-2407-14-570

You can find further information about peer review here.

Back to article page